Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

Similar articles for PubMed (Select 20001736)

1.

Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.

Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, Pondo T, Arnold KE, Baumbach J, Bennett N, Craig AS, Farley M, Gershman K, Petit S, Lynfield R, Reingold A, Schaffner W, Shutt KA, Zell ER, Mayer LW, Clark T, Stephens D, Messonnier NE.

Clin Infect Dis. 2010 Jan 15;50(2):184-91. doi: 10.1086/649209.

2.

Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.

Poland GA.

Clin Infect Dis. 2010 Mar 1;50 Suppl 2:S45-53. doi: 10.1086/648964. Review.

3.

Prevention of meningococcal disease.

Kimmel SR.

Am Fam Physician. 2005 Nov 15;72(10):2049-56. Review.

4.

Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.

Noronha CP, Struchiner CJ, Halloran ME.

Int J Epidemiol. 1995 Oct;24(5):1050-7.

PMID:
8557439
5.

Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.

Lingappa JR, Rosenstein N, Zell ER, Shutt KA, Schuchat A, Perkins BA; Active Bacterial Core surveillance (ABCs) team.

Vaccine. 2001 Aug 14;19(31):4566-75.

PMID:
11483285
6.

Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.

Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, Zhang X, Stephens DS, Messonnier NE; Active Bacterial Core Surveillance Team.

Clin Infect Dis. 2008 Jan 1;46(1):1-13. doi: 10.1086/524041.

7.

Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.

Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE; ABCs Team.

Pediatrics. 2005 May;115(5):1220-32.

PMID:
15867028
8.

Optimizing protection against meningococcal disease.

Reisinger KS, Black S, Stoddard JJ.

Clin Pediatr (Phila). 2010 Jun;49(6):586-97. doi: 10.1177/0009922809354327. Epub 2010 Jan 20. Review.

PMID:
20089551
9.
10.

Epidemiology of infant meningococcal disease in the United States, 2006-2012.

MacNeil JR, Bennett N, Farley MM, Harrison LH, Lynfield R, Nichols M, Petit S, Reingold A, Schaffner W, Thomas A, Pondo T, Mayer LW, Clark TA, Cohn AC.

Pediatrics. 2015 Feb;135(2):e305-11. doi: 10.1542/peds.2014-2035. Epub 2015 Jan 12.

PMID:
25583921
12.

Meningococcal disease and vaccination in North America.

Pollard AJ, Scheifele D.

J Paediatr Child Health. 2001 Oct;37(5):S20-7.

PMID:
11885732
13.

Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.

Pace D.

Expert Rev Vaccines. 2009 May;8(5):529-42. doi: 10.1586/erv.09.18. Review.

PMID:
19397410
14.

Prevention of meningococcal disease.

Woodard JL, Berman DM.

Fetal Pediatr Pathol. 2006 Nov-Dec;25(6):311-9. Review.

PMID:
17696042
15.

The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.

O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C; Active Bacterial Core Surveillance Team.

Clin Infect Dis. 2007 Oct 1;45(7):853-62. Epub 2007 Aug 29.

16.

Meningococcal disease.

Memish ZA, Alrajhi AA.

Saudi Med J. 2002 Mar;23(3):259-64. Review.

PMID:
11938412
17.

The changing epidemiology of meningococcal disease in the United States, 1992-1996.

Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, Cieslak P, Shutt KA, Popovic T, Schuchat A, Harrison LH, Reingold AL.

J Infect Dis. 1999 Dec;180(6):1894-901.

18.

Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.

Cardeñosa N, Domínguez A, Martínez A, Alvarez J, Pañella H, Godoy P, Minguell S, Camps N, Vázquez JA; Working Group on Meningococcal Disease.

Infection. 2003 Dec;31(6):392-7.

PMID:
14735381
19.

Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96.

Campagne G, Schuchat A, Djibo S, Ousséini A, Cissé L, Chippaux JP.

Bull World Health Organ. 1999;77(6):499-508.

20.

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.

Novak RT, Kambou JL, Diomandé FV, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L, Lingani C, Martin SW, Hatcher C, Mayer LW, Laforce FM, Avokey F, Djingarey MH, Messonnier NE, Tiendrébéogo SR, Clark TA.

Lancet Infect Dis. 2012 Oct;12(10):757-64. doi: 10.1016/S1473-3099(12)70168-8. Epub 2012 Jul 18.

PMID:
22818241
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk